Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss

NCT06029673 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Lactation Suppressed

Interventions

DRUG: Cabergoline 1 MG
DRUG: Placebo

Sponsor

Stanford University

Collaborators

[object Object]